{"entity":{"type":"insider","cik":"0002036234","url":"/insider/0002036234","json_url":"/insider/0002036234.json","name":"de Verneuil Vanina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2024-11-05","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"de Verneuil Vanina","source":"filing","n_filings":9,"first_seen":"2024-11-05","last_seen":"2026-02-26"}],"transactions":[{"id":5814253,"accession":"0001628280-26-012393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-012393","line_url":"/filing/0001628280-26-012393#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP, General Counsel, Corp Sec)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel, Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel, Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13700.0,"shares_display":"13,700","price_per_share":9.82,"price_display":"9.82","price_state":"stated","total_value":134534.0,"total_display":"134,534.00","total_whole":"134,534","shares_owned_after":112982.0,"shares_owned_after_display":"112,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":5814252,"accession":"0001628280-26-012393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-012393","line_url":"/filing/0001628280-26-012393#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP, General Counsel, Corp Sec)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel, Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel, Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3117.0,"shares_display":"3,117","price_per_share":9.5326,"price_display":"9.53","price_state":"stated","total_value":29713.1142,"total_display":"29,713.11","total_whole":"29,713","shares_owned_after":126682.0,"shares_owned_after_display":"126,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":6023339,"accession":"0001628280-26-011328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-011328","line_url":"/filing/0001628280-26-011328#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP, General Counsel, Corp Sec)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel, Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel, Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4445.0,"shares_display":"4,445","price_per_share":7.4528,"price_display":"7.45","price_state":"stated","total_value":33127.696,"total_display":"33,127.70","total_whole":"33,128","shares_owned_after":129799.0,"shares_owned_after_display":"129,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":4960679,"accession":"0001628280-25-050592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-050592","line_url":"/filing/0001628280-25-050592#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP, General Counsel, Corp Sec)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel, Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel, Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2385.0,"shares_display":"2,385","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":12306.6,"total_display":"12,306.60","total_whole":"12,307","shares_owned_after":78210.0,"shares_owned_after_display":"78,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-07","scope":"insider"},{"id":4033191,"accession":"0001628280-25-049159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-049159","line_url":"/filing/0001628280-25-049159#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1365.0,"shares_display":"1,365","price_per_share":5.863,"price_display":"5.86","price_state":"stated","total_value":8002.995,"total_display":"8,003.00","total_whole":"8,003","shares_owned_after":80595.0,"shares_owned_after_display":"80,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-04","scope":"insider"},{"id":4385768,"accession":"0001628280-25-008499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-008499","line_url":"/filing/0001628280-25-008499#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7373.0,"shares_display":"7,373","price_per_share":9.1418,"price_display":"9.14","price_state":"stated","total_value":67402.4914,"total_display":"67,402.49","total_whole":"67,402","shares_owned_after":79460.0,"shares_owned_after_display":"79,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-26","filed_date":"2025-02-27","scope":"insider"},{"id":4204918,"accession":"0001628280-25-007690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-007690","line_url":"/filing/0001628280-25-007690#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5140.0,"shares_display":"5,140","price_per_share":9.4534,"price_display":"9.45","price_state":"stated","total_value":48590.476,"total_display":"48,590.48","total_whole":"48,590","shares_owned_after":86833.0,"shares_owned_after_display":"86,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider"},{"id":2830378,"accession":"0001628280-24-049897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-049897","line_url":"/filing/0001628280-24-049897#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76.0,"shares_display":"76","price_per_share":8.2201,"price_display":"8.22","price_state":"stated","total_value":624.7276,"total_display":"624.73","total_whole":"625","shares_owned_after":56973.0,"shares_owned_after_display":"56,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2970417,"accession":"0001628280-24-046462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-046462","line_url":"/filing/0001628280-24-046462#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4397.0,"shares_display":"4,397","price_per_share":10.11,"price_display":"10.11","price_state":"stated","total_value":44453.67,"total_display":"44,453.67","total_whole":"44,454","shares_owned_after":56973.0,"shares_owned_after_display":"56,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-07","scope":"insider"},{"id":2871353,"accession":"0001628280-24-045387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-045387","line_url":"/filing/0001628280-24-045387#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2347.0,"shares_display":"2,347","price_per_share":9.4696,"price_display":"9.47","price_state":"stated","total_value":22225.1512,"total_display":"22,225.15","total_whole":"22,225","shares_owned_after":61370.0,"shares_owned_after_display":"61,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-05","scope":"insider"},{"id":2871351,"accession":"0001628280-24-045387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-045387","line_url":"/filing/0001628280-24-045387#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0002036234","owner_name":"de Verneuil Vanina","owner_display_name":"de Verneuil Vanina","owner_url":"/insider/0002036234","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1403.0,"shares_display":"1,403","price_per_share":7.2039,"price_display":"7.20","price_state":"stated","total_value":10107.0717,"total_display":"10,107.07","total_whole":"10,107","shares_owned_after":63717.0,"shares_owned_after_display":"63,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Officer (EVP, General Counsel, Corp Sec)","n_filings":9,"first_seen":"2024-11-05","last_seen":"2026-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002036234","retrieved_at":"2026-08-23T11:46:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}